Nuvectis Pharma, Inc. is in its Saturn mahadasha (4 Feb 2022 to 8 Nov 2037), Venus antardasha (30 Aug 2025 to 30 Oct 2028) and Rahu pratyantar (19 Oct 2026 to 10 Apr 2027).
Next: pratyantar Jupiter from 10 Apr 2027; antardasha Sun from 30 Oct 2028; mahadasha Mercury from 8 Nov 2037.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Makara (Capricorn) | 21°36′ | 11th | Shravana 4 |
| Moon | Meena (Pisces) | 5°36′ | 1st | Uttara Bhadrapada 1 |
| Mars | Dhanu (Sagittarius) | 13°55′ | 10th | Purva Ashadha 1 |
| Mercury | Makara (Capricorn) | 0°14′ | 11th | Uttara Ashadha 2 |
| Jupiter | Kumbha (Aquarius) | 13°54′ | 12th | Shatabhisha 3 |
| Venus | Dhanu (Sagittarius) | 17°41′ | 10th | Purva Ashadha 2 |
| Saturn | Makara (Capricorn) | 21°46′ | 11th | Shravana 4 |
| Rahu | Vrishabha (Taurus) | 3°33′ | 3rd | Krittika 3 |
| Ketu | Vrishchika (Scorpio) | 3°33′ | 9th | Anuradha 1 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how NVCT moved in each period against the S&P 500, transits, fundamentals and news.